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316 THE DETERMINANTS OF SEEKING HELP FROM HEALTH
CARE PROFESSIONALS BY PEOPLE WITH LOWER LIMB
PAIN
C. Thorstensson1, R. Gooberman-Hill2, S. Williams2, P.A. Dieppe3.
1Spenshult Hospital, Spenshult, SWEDEN, 2Department of Social
Medicine, University of Bristol, UNITED KINGDOM, 3Nufﬁeld
Department of Orthopaedic Surgery, University of Oxford, UNITED
KINGDOM
Purpose: To explore the determinants of help seeking by people in the
community, who have lower limb pain.
Methods: Health care utilisation, deﬁned as having seen a family doctor
(GP) or hospital doctor during the past 12 months; or an allied health
professional (AHP) or alternative therapist during the past 3 months,
was assessed in 1079 persons reporting lower limb (hip/knee) pain
from a community based sample aged 35 or over (The Somerset and
Avon Survey of Health, SASH). Age and gender adjusted odds ratios
were determined for: ethnicity, social deprivation, rurality, pain intensity
(1−10, best-worst), the EQ5D mobility and anxiety/depression questions,
the number of other self-reported health problems, and standard WHO
categories of body mass index (BMI). A two-step cluster analysis was
also performed to test associations between the variables.
Results: Of the 1079 persons reporting pain in the hip or knee 18% had
seen a doctor only, 2% an AHP only, and 4% an alternative therapist
only. 22% had seen more than one category of health care professionals
(categorised ‘COMB’). 54% had not seen any health care professional.
People with mobility problems were 5 times more likely to visit an AHP
(OR (95% CI) 5.54 (1.60−19.23)), and 3−4 times more likely to visit a GP
(3.34 (2.19−5.08)), hospital doctor (2.83 (1.39−5.75)), or COMB (4.43
(3.06−6.43). Having two or more comorbidities doubled the likelihood
of seeing a GP (2.43 (1.27−4.64)) and ‘COMB’ (1.89 (1.13−3.16)), and
caused a 3-fold increased likelihood of seeing a hospital doctor (3.36
(1.06−10.57)) or alternative therapist (3.48 (1.22−9.91)). Pain severity
was weakly associated with a visit to a GP (1.35 (1.22−1.50) or ‘COMB’
(1.57 (1.43−1.72)). A visit to a GP was also associated with living in urban
areas (2.46 (1.24−4.88)) and obesity (2.34 (1.42−3.88)). Seeking ‘COMB’
was associated with anxiety/depression (1.78 (1.30−2.43)), overweight
(2.05 (1.34−3.13)) and obesity (2.50 (1.59−3.92)).
The cluster analysis showed that more severe pain, mobility problems,
more health problems, obesity, female gender and higher age were all
associated with each other, and that people from this cluster were more
likely to see a GP, hospital doctor, AHP and COMB, although 46% of
those not currently using health care also belonged to this cluster.
Conclusions: A majority of people living with hip and knee pain in the
community do not seek help from health care professionals. Pain severity
and perceived anxiety/depression seem to be of less importance to help
seeking than reduced mobility, obesity, and comorbidities. People may
cope well with hip and knee pain alone, but if they have other health
problems or signiﬁcant disability as well, they are more likely to seek
professional help.
317 THE INFLUENCE OF PATIENTS’ GENDER ON PHYSICIANS’
INTERPERSONAL BEHAVIOUR REGARDING TOTAL KNEE
ARTHROPLASTY: WHAT IF YOUR PHYSICIAN DOESN’T ASK
YOU TO DANCE?
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Purpose: Physicians are more likely to recommend total knee arthro-
plasty (TKA) to a man than to a woman, suggesting that physicians
may be at least partially responsible for the gender disparity in the
utilization of TKA. The extent to which physicians involve their patients
in informed decision making regarding TKA and whether this differs
when the patient is a man or woman is unknown. The purpose of this
study was to investigate the effect of patients’ gender on the interaction
between family physicians and the patient in the process of referral to an
orthopaedic surgeon and between orthopaedic surgeons and the patient
in the process of recommendation for total knee arthroplasty.
Methods: Seventy-one physicians (38 family physicians and 33 or-
thopaedic surgeons) in Ontario, Canada performed blinded assessments
of two standardized patients (one man and one woman) with moderate
knee osteoarthritis and otherwise identical scenarios differing only in
gender. Four surgeons did not consent to including their data. Physicians
were told that they were participating in a study of clinical decision mak-
ing. Our SPs were also not informed of this study’s purpose. Standardized
patients and accompanying mock family members recorded 42 items
summarized as 7 elements of informed decision making (IDM) present
(yes/no) in the patient-physician interaction, based on Braddock’s IDM
Scale and rated physicians’ interpersonal skills.
Results: Overall, the completeness of informed decision making was
low but lower still for the woman. Only 57% (38/67) and 15% (10/67) of
physicians discussed the nature of the decision and elicited the patients’
preference, while consulting the man and woman, respectively. Even after
adjusting for physicians’ recommendations regarding TKA, physicians
when interacting with the woman, included fewer IDM elements (mean
difference in IDM score, 1.2; 95% CI 0.6−1.8; P< 0.001) and had poorer
interpersonal skills (mean difference, 14.1; 95% CI 9.0−19.2; P< 0.001)
compared with their interaction with the man. Though physicians recom-
mending TKA had a more participatory decision making style, they still
included 1.6 fewer IDM elements (P=0.001) and had poorer interpersonal
skills (P< 0.001) when the patient was a woman compared to a man.
Conclusions: Physicians provided less medical information and less
encouragement to participate in the decision to undergo TKA to a woman
compared with a man, irrespective of their recommendation regarding
TKA. Our ﬁndings suggest that in addition to directly inﬂuencing physi-
cians’ clinical decision making, gender bias may also inﬂuence physicians’
interpersonal behaviour and thereby contribute to the gender disparity
in the utilization of TKA. Because educational interventions designed to
improve patient-physician communication are likely to target physicians’
conscious beliefs rather than unconscious stereotypes about patients,
they are probably not sufﬁcient to address physicians’ biases. Our ﬁndings
support the need for an additional skills component to patient-based
care that provides physicians with the capacity to consciously replace
automatically activated stereotypes.
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Purpose: In a previous longitudinal analysis we found that higher femoral
neck (FN) and whole body BMD were associated with an increased risk
of incident tibiofemoral radiographic knee OA (RKOA) and joint space
narrowing (JSN) in knees without baseline RKOA (K-L grade< 2) and in
knees with K-L grade=0, but found no association with JSN progression
in knees with existing RKOA. In this study, we examined whether BMD is
associated with the risk of cartilage loss (CL), assessed by MRI, in knees
with and without tibiofemoral RKOA.
Methods: Subjects were from MOST, an NIH-supported observational
study of 3026 persons with knee OA or at high risk of disease. Total body
and right femoral neck (FN) BMD were measured (Hologic 4500A) at
baseline and subjects categorized by gender-speciﬁc quartiles. Baseline
PA ﬁxed ﬂexion knee x-rays were assessed for K-L grade and full limb
ﬁlms measured for knee alignment. MRIs were obtained at baseline
and 30 months on a 1.0T extremity scanner (ONI Medical Systems,
OrthOneTM) using axial and sagittal proton density fat-suppressed and
coronal STIR sequences. Paired MRIs were read in known order by mus-
culoskeletal radiologists for CL in each of 10 tibofemoral (TF) subregions
using WORMS. TF CL was deﬁned as an increase between timepoints
of 1 grade (excluding changes from 0 to 1-signal abnormality) in an
individual subregion. BMD as a predictor of number of TF subregions
with CL in a knee was analyzed in one knee per person using Poisson
regression, adjusting for age, gender, BMI, quadriceps strength and
current use of bone antiresorptive agents.
Results: 711 white men (38%) and women (mean age 63.2±7.8) had
BMD and CL data in at least one knee with a baseline KL grade of 0−3.
CL in one or more TF subregions occurred in 28.9% of KL 0−1 and 40.8%
of KL 2−3 knees. The association of BMD with CL was similar by gender.
Compared to the lowest BMD quartile, higher quartiles were associated
with increased CL in K-L = 0−1 knees (table). In KL=0 knees, the upper
3 FN BMD quartiles had an increased risk of CL, RR 2.5 (1.1 6.1). There
were no signiﬁcant associations of BMD with CL in knees with existing
RKOA, even when malaligned knees were excluded.
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Conclusions: This is the ﬁrst study to demonstrate that higher BMD in
men and women is associated with tibiofemoral cartilage loss on MRI
in knees without RKOA, including K-L grade 0 knees. We also conﬁrm
previous ﬁndings from radiographs in this cohort that BMD is weakly,
or not all, associated with structural progression in knees with existing
RKOA.
Table. BMD quartiles and relative risk of cartilage loss, by baseline K-L grade












Q1-lowest 39 (3.9) 1.0 ref 61 (7.4) 1.0 ref
Q2 75 (7.7) 2.0 (1.1, 3.8) 60 (6.8) 1.0 (0.6, 1.6)
Q3 49 (5.4) 1.3 (0.7, 2.7) 93 (9.8) 1.4 (0.9, 2.2)
Q4-highest 73 (7.5) 2.1 (1.1, 4.1) 80 (9.2) 1.4 (0.9, 2.2)
P-value trend 0.084 0.080
Q 2−4 vs Q1 197 (6.9) 1.8 (1.03, 3.2) 233 (8.6) 1.2 (0.8, 1.8)
Whole body BMD quartile
Q1-lowest 37 (4.2) 1.0 ref 68 (7.3) 1.0 ref
Q2 59 (5.5) 1.4 (0.7, 2.6) 73 (9.6) 1.3 (0.8, 2.0)
Q3 60 (6.1) 1.6 (0.9, 3.1) 73 (8.5) 1.2 (0.7, 1.8)
Q4-highest 80 (8.9) 2.5 (1.3, 4.7) 77 (8.2) 1.1 (0.7, 1.8)
P-value trend 0.001 0.791
Q 2−4 vs Q1 199 (6.7) 1.7 (1.05, 3.0) 223 (8.7) 1.2 (0.8, 1.8)
319 PREVENTION OF KNEE OSTEOARTHRITIS IN OVERWEIGHT
FEMALES; FROM FEASIBILITY TRIAL TO FULL-SCALE
TRIAL
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Purpose: In the present study we will test the preventive effect of a tailor
made intervention for reducing weight as well as of an intervention with
oral crystalline glucosamine sulphate in a factorial design in a high-risk
group of overweight middle aged women who have not yet consulted for
knee osteoarthritis (OA).
Methods: 40 general practitioners (GPs) will contact all registered women
between 50 and 60 years of age without major co-morbidities. After
telephonic screening, 400 women with a BMI  27 who have not yet
consulted for knee pain will be included in this study. At baseline, X-rays
and MRIs will be made of both knees to measure presence and amount of
OA features. Presence of radiological signs indicating knee OA (Kellgren-
Lawrence index of 2 or more) and knee OA according to the ACR criteria
are exclusion criteria. From serum and urine samples serum glucose,
serum cholesterol, levels of bone and cartilage degeneration markers and
inﬂammation markers will be determined. Through physical examination
weight, length, blood pressure, skin fold, pain on pressure of the joint
margins, and crepitation of the knee joint will be measured. All participants
ﬁll in a questionnaire to measure knee complaints (WOMAC), activity level
(SQUASH), menopausal status, co-morbidity, medical consumption, co-
interventions, and quality of live (Euroqol).
After baseline measurements, participants will be randomised over four
groups. Half of all participants will be allocated to a tailor made interven-
tion of half a year to reduce weight (consisting of physical activity classes
and several consultations with a dietician); the other half will not receive
this intervention. Secondly, in both groups half of the participants will
be randomised to receive 1500mg oral crystalline glucosamine sulphate
once a day for two and a half year while the other half will receive
a placebo. After two and a half year, baseline measurements will be
repeated. The full-scale trial was preceded by a pilot trial. In this feasibility
trial procedures, compliance and effects of the intervention were tested
during a one year follow-up.
Results: 1365 women were contacted by 10 GPs. Of these 353 women
returned a response to our research centre (26%). 184 were excluded
after telephonic screening because they did not meet the inclusion criteria
(52%). Of the remaining 93 (55%) were willing to participate and were
included in the study and followed for one year according the above-
mentioned protocol.
After 6 months, 89% of the participants had taken more than 75% of the
glucosamine or placebo. At the end of the feasibility study, 73% of the
women allocated to the tailor made intervention have visited the physical
activity classes and 84% of them had al least one consultation with the
dietician. 28% of the women in the weight reduction group showed a
weight reduction of 5 kg and/or 5% reduction of the baseline weight
versus 13% in the other group. At one year, only 4% is lost to follow-
up. On the baseline MRIs, 20% of the women showed osteochondral
defects on the patella and 10% on the medial and lateral condyle of the
femur. Osteophytes were found on the patella and on the lateral and
medial condyle of the femur (all in 10% of the women). Over 50% of the
women showed degeneration of the medial meniscus and 35% of the
lateral meniscus. At one year follow-up, 5% of the cases or less showed
progression of the knee OA related features on the MRIs.
Conclusions: Based on the results of the pilot trial, a full-scale trial
seems to be feasible. Therefore all participants of the pilot trial will be
followed for another one and a half year and 307 new participants will be
gathered according to above-mentioned protocol.
320 SELF-REPORTED ADHERENCE TO CHONDROPROTECTIVE
REGIMEN IN OSTEOARTHRITIS
G. Rovetta III1, S. Paolo2, P. Monteforte3, A. Brignone4. 1University of
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Purpose: The objective of our study was to explore the (OA) of the knee,
hip, hand, and in vertebral OA.
Methods: We performed a retrospective study involving 497 patients
who did receive a chondroprotective treatment [Glucosamine 500mg +
Chondroitin-sulphate (CSbBio-ActiveTM) 500mg), and native collagen
type II (1mg) once a day] for their painful osteoarthritis during 12 months.
Knee OA was present in 234 pts, hip OA in 78, hand OA in 124, cervical
OA in 26 and lumbar OA in 35 pts. For deﬁning treatment adherence
levels, a self reported information recorded on patient’s ﬁle was examined
and a cut-off of 70% was established.
Adherence to chondroprotective treatment in OA.
Results: During the 12 months of observation, the level of adherence
>70% was maintained for 22/78 of hip OA, 185/234 for knee OA, 10/26
for cervical OA, 15/35 for lumbar OA and 98/124 for hand OA; the overall
number of adherents was 330 and 167 discontinued the chondroprotec-
tive treatment. Patients affected with peripheral OA did maintain the >70%
treatment adherence greater than pts with vertebral OA (p> 0.01). The
difference between hip sufferers and knee sufferers was signiﬁcant. The
difference between hand and knee sufferers was not signiﬁcant.
Conclusions: People who are prescribed self-administered medications
generally take less than the prescribed doses. Increasing adherence to
medications might improve the beneﬁts, but also might increase adverse
effects of medications. This is not the case of chondroprotective treat-
ment, which has in toxicology studies an excellent tolerance proﬁle. In our
observation, a quite satisfactory adherence was present only in sufferers
of knee OA and hand OA. Ameliorating adherence may possibly improve
patient outcomes.
321 THE VECTRA STUDY: ECONOMIC AND HEALTH
ASSESSMENT OF CHONDROITIN SULFATE FOR
OSTEOARTHRITIS TREATMENT
C. Rubio. Health value, Madrid, SPAIN
Purpose: To estimate the average cost per patient with osteoarthritis,
treated with CS or NSAID for 6 months, and the possible consequences
that the reduction on the consumption of NSAID due to CS treatment
may have on the budget impact for the Spanish National Health System
(NHS).
